"Probiotic Breakthrough: Transforming Autoimmune Treatment"
Researchers at Brigham and Women's Hospital have developed a genetically engineered probiotic that targets autoimmunity in the brain, offering a potential breakthrough in the treatment of diseases like multiple sclerosis. The probiotic bacteria produce lactate, which helps regulate immune responses and reduce brain inflammation in mouse models. This approach shows promise in providing a more precise and effective way to treat autoimmune conditions in the brain, with fewer side effects compared to standard therapies. The researchers are optimistic about translating this approach into clinical use and are also exploring its application for other autoimmune diseases.